Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Current Assets (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Current Assets for 5 consecutive years, with $450.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Current Assets fell 6.53% to $450.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $450.4 million, a 6.53% decrease, with the full-year FY2025 number at $450.4 million, down 6.53% from a year prior.
  • Current Assets was $450.4 million for Q4 2025 at PROCEPT BioRobotics, down from $454.8 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $481.8 million in Q4 2024 to a low of $230.0 million in Q2 2023.
  • A 5-year average of $354.1 million and a median of $327.7 million in 2021 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: fell 22.9% in 2023, then soared 42.3% in 2025.
  • PROCEPT BioRobotics' Current Assets stood at $326.2 million in 2021, then fell by 16.42% to $272.6 million in 2022, then increased by 28.59% to $350.6 million in 2023, then soared by 37.45% to $481.8 million in 2024, then dropped by 6.53% to $450.4 million in 2025.
  • Per Business Quant, the three most recent readings for PRCT's Current Assets are $450.4 million (Q4 2025), $454.8 million (Q3 2025), and $458.1 million (Q2 2025).